Agilon Health (AGL) Stock Analysis & Winston Score
Agilon Health helps primary care doctors take better care of elderly patients on Medicare. The company partners with physician groups across the United States and takes on the financial responsibility for managing those patients' total healthcare costs. It operates in the Medicare Advantage market, where health insurers pay a fixed amount per patient rather than per service. Agilon makes money by receiving capitated payments — fixed monthly fees per patient — from Medicare Advantage health plans, then paying for all the medical care those patients need. It operates in multiple U.S. markets and has been growing its network of physician partners. The core idea is that keeping patients healthier costs less, which is how the company aims to eventually turn a profit. However, the company is currently losing money, with medical costs running higher than the payments it receives, and its ability to reach profitability depends heavily on improving how well it manages patient health expenses.
Winston Score: 22/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (4/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $129.84
Market Cap: $2.2B
Sector: Healthcare
Industry: Medical - Care Facilities
Exchange: New York Stock Exchange
